Not logged inRe: Singh et al.: Nepafenac 0.3% after cataract surgery in patients with diabetic retinopathy: result of 2 randomized phase 3 studies (Ophthalmology. 2017; 124: 776-785) REPLY
Singh, Rishi P.; Lehmann, Robert; Martel, Joseph; Jong, Kevin; Pollack, Ayala; Tsorbatzoglou, Alexis; Staurenghi, Giovanni; Cervantes-Coste Cervantes, Guadalupe; Alpern, Louis; Modi, Satish; Svoboda, Liza; Adewale, Adeniyi; Jaffe, Glenn J. .png)
Share.png)
SaveRe: Singh et al.: Nepafenac 0.3% after cataract surgery in patients with diabetic retinopathy: results of 2 randomized phase 3 studies (Ophthalmology. 2017;124:776-785) REPLYSingh, Rishi P.; Lehmann, Robert; Martel, Joseph; Jong, Kevin; Pollack, Ayala; Tsorbatzoglou, Alexis; Staurenghi, Giovanni; Cervantes-Coste Cervantes, Guadalupe; Alpern, Louis; Modi, Satish; Svoboda, Liza; Adewale, Adeniyi; Jaffe, Glenn J. Share Save Re: Re: Singh et al.: Nepafenac 0.3% after cataract surgery in patients with diabetic retinopathy: results of 2 randomized phase 3 studies (Ophthalmology. 2017;124:776-785) REPLYSingh, Rishi P.; Lehmann, Robert; Martel, Joseph; Jong, Kevin; Pollack, Ayala; Tsorbatzoglou, Alexis; Staurenghi, Giovanni; Cervantes-Coste Cervantes, Guadalupe; Alpern, Louis; Modi, Satish; Svoboda, Liza; Adewale, Adeniyi; Jaffe, Glenn J. Share Save Nepafenac 0.3% after Cataract Surgery in Patients with Diabetic RetinopathySingh, Rishi P.; Lehmann, Robert; Martel, Joseph; Jong, Kevin; Pollack, Ayala; Tsorbatzoglou, Alexis; Staurenghi, Giovanni; Cervantes, Guadalupe Cervantes-Coste; Alpern, Louis; Modi, Satish; Svoboda, Liza; Adewale, Adeniyi; Jaffe, Glenn J. Share Save Share Save Share Save Share Save Share Save Share Save Share Save Share Save Share Save Share Save 
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}